Groupama Asset Managment Buys New Holdings in Globe Life Inc. $GL

Groupama Asset Managment purchased a new position in Globe Life Inc. (NYSE:GLFree Report) during the first quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund purchased 3,347 shares of the company’s stock, valued at approximately $466,000.

Other hedge funds and other institutional investors have also recently bought and sold shares of the company. Edgestream Partners L.P. purchased a new stake in shares of Globe Life during the first quarter valued at approximately $7,513,000. Bull Harbor Capital LLC purchased a new position in shares of Globe Life in the first quarter worth $538,000. Amundi raised its holdings in Globe Life by 627.5% during the 1st quarter. Amundi now owns 39,821 shares of the company’s stock valued at $5,542,000 after buying an additional 34,347 shares during the last quarter. EverSource Wealth Advisors LLC raised its holdings in Globe Life by 4.0% during the 1st quarter. EverSource Wealth Advisors LLC now owns 2,366 shares of the company’s stock valued at $329,000 after buying an additional 91 shares during the last quarter. Finally, California State Teachers Retirement System boosted its position in Globe Life by 18.0% during the 1st quarter. California State Teachers Retirement System now owns 90,478 shares of the company’s stock valued at $12,592,000 after buying an additional 13,806 shares during the period. Institutional investors own 81.61% of the company’s stock.

Insider Transactions at Globe Life

In other Globe Life news, Director Cheryl Alston sold 8,258 shares of the company’s stock in a transaction that occurred on Thursday, June 25th. The stock was sold at an average price of $179.24, for a total transaction of $1,480,163.92. Following the transaction, the director owned 16,621 shares in the company, valued at approximately $2,979,148.04. This represents a 33.19% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, EVP Michael Clay Majors sold 37,000 shares of the stock in a transaction that occurred on Wednesday, July 29th. The stock was sold at an average price of $178.64, for a total value of $6,609,680.00. Following the completion of the transaction, the executive vice president directly owned 53,518 shares of the company’s stock, valued at $9,560,455.52. This represents a 40.88% decrease in their position. The disclosure for this sale is available in the SEC filing. In the last 90 days, insiders sold 169,174 shares of company stock valued at $28,553,849. Insiders own 2.11% of the company’s stock.

Wall Street Analysts Forecast Growth

A number of brokerages have issued reports on GL. Keefe, Bruyette & Woods cut their price target on shares of Globe Life from $192.00 to $190.00 and set an “outperform” rating on the stock in a report on Friday, July 24th. Weiss Ratings downgraded shares of Globe Life from a “buy (b)” rating to a “buy (b-)” rating in a research note on Monday, July 20th. Piper Sandler raised their target price on Globe Life from $175.00 to $200.00 and gave the stock an “overweight” rating in a research note on Wednesday, July 15th. Morgan Stanley boosted their price target on Globe Life from $181.00 to $208.00 and gave the company an “overweight” rating in a report on Monday, July 6th. Finally, TD Cowen upped their price target on Globe Life from $215.00 to $225.00 and gave the company a “buy” rating in a research report on Wednesday, July 22nd. One research analyst has rated the stock with a Strong Buy rating, eight have issued a Buy rating and two have given a Hold rating to the company’s stock. According to MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and a consensus target price of $191.67.

View Our Latest Report on GL

Globe Life Trading Down 0.1%

NYSE:GL opened at $182.14 on Monday. The company has a 50-day moving average price of $171.52 and a 200-day moving average price of $154.34. The stock has a market cap of $14.14 billion, a price-to-earnings ratio of 12.09 and a beta of 0.48. The company has a current ratio of 0.07, a quick ratio of 0.07 and a debt-to-equity ratio of 0.38. Globe Life Inc. has a 12 month low of $127.85 and a 12 month high of $191.55.

Globe Life (NYSE:GLGet Free Report) last announced its quarterly earnings results on Wednesday, July 22nd. The company reported $3.61 earnings per share (EPS) for the quarter, missing the consensus estimate of $3.67 by ($0.06). Globe Life had a net margin of 19.58% and a return on equity of 20.73%. The company had revenue of $1.60 billion for the quarter, compared to analysts’ expectations of $1.59 billion. During the same quarter in the prior year, the firm earned $3.05 EPS. Globe Life’s quarterly revenue was up 8.0% compared to the same quarter last year. Globe Life has set its FY 2026 guidance at 15.550-15.950 EPS. Equities analysts predict that Globe Life Inc. will post 15.7 EPS for the current year.

About Globe Life

(Free Report)

Globe Life, traded on the NYSE under the symbol GL, is a U.S.-based insurance holding company that underwrites and distributes a range of life and supplemental health insurance products. Through its subsidiary brands—Globe Life, American Income Life, Liberty National Life, United American Insurance Company and Family Heritage Life—it offers term life, whole life, fixed annuities and supplemental health coverage designed to meet the needs of individuals and families across various socioeconomic segments.

The company’s product suite includes low-cost, easy-to-understand life insurance policies, accidental death and dismemberment coverage, hospital indemnity plans and specified disease insurance.

See Also

Want to see what other hedge funds are holding GL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Globe Life Inc. (NYSE:GLFree Report).

Institutional Ownership by Quarter for Globe Life (NYSE:GL)

Receive News & Ratings for Globe Life Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Globe Life and related companies with MarketBeat.com's FREE daily email newsletter.